These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3367156)

  • 1. 31P nuclear magnetic resonance study of the brain in Alzheimer's disease.
    Pettegrew JW; Moossy J; Withers G; McKeag D; Panchalingam K
    J Neuropathol Exp Neurol; 1988 May; 47(3):235-48. PubMed ID: 3367156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 31P magnetic resonance spectroscopy in Alzheimer's and Pick's disease.
    Smith CD; Gallenstein LG; Layton WJ; Kryscio RJ; Markesbery WR
    Neurobiol Aging; 1993; 14(1):85-92. PubMed ID: 8450937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease.
    Pettegrew JW; Panchalingam K; Moossy J; Martinez J; Rao G; Boller F
    Arch Neurol; 1988 Oct; 45(10):1093-6. PubMed ID: 3178529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro 31P NMR spectroscopy detects altered phospholipid metabolism in Alzheimer's disease.
    Miatto O; Gonzalez RG; Buonanno F; Growdon JH
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):535-9. PubMed ID: 3791069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional
    Rijpma A; van der Graaf M; Meulenbroek O; Olde Rikkert MGM; Heerschap A
    Neuroimage Clin; 2018; 18():254-261. PubMed ID: 29876246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 31P nuclear magnetic resonance (NMR) spectroscopy of brain in aging and Alzheimer's disease.
    Pettegrew JW; Withers G; Panchalingam K; Post JF
    J Neural Transm Suppl; 1987; 24():261-8. PubMed ID: 3316499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia.
    Brown GG; Levine SR; Gorell JM; Pettegrew JW; Gdowski JW; Bueri JA; Helpern JA; Welch KM
    Neurology; 1989 Nov; 39(11):1423-7. PubMed ID: 2812317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial.
    Rijpma A; van der Graaf M; Lansbergen MM; Meulenbroek O; Cetinyurek-Yavuz A; Sijben JW; Heerschap A; Olde Rikkert MGM
    Alzheimers Res Ther; 2017 Jul; 9(1):51. PubMed ID: 28747210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study.
    Forlenza OV; Wacker P; Nunes PV; Yacubian J; Castro CC; Otaduy MC; Gattaz WF
    Psychopharmacology (Berl); 2005 Jul; 180(2):359-65. PubMed ID: 15700180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
    Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
    Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance spectroscopy and its application to aging and Alzheimer's disease.
    McClure RJ; Kanfer JN; Panchalingam K; Klunk WE; Pettegrew JW
    Neuroimaging Clin N Am; 1995 Feb; 5(1):69-86. PubMed ID: 7743086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brain.
    Klunk WE; Xu C; Panchalingam K; McClure RJ; Pettegrew JW
    Neurobiol Aging; 1996; 17(3):349-57. PubMed ID: 8725895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study.
    Pettegrew JW; Panchalingam K; Klunk WE; McClure RJ; Muenz LR
    Neurobiol Aging; 1994; 15(1):117-32. PubMed ID: 8159258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of hippocampal pH and neurochemicals from in vivo multi-voxel 31P study in healthy normal young male/female, mild cognitive impairment, and Alzheimer's disease.
    Mandal PK; Akolkar H; Tripathi M
    J Alzheimers Dis; 2012; 31 Suppl 3():S75-86. PubMed ID: 22426021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated.
    Hanger DP; Brion JP; Gallo JM; Cairns NJ; Luthert PJ; Anderton BH
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):99-104. PubMed ID: 1826835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal cerebral phospholipid metabolism in dyslexia indicated by phosphorus-31 magnetic resonance spectroscopy.
    Richardson AJ; Cox IJ; Sargentoni J; Puri BK
    NMR Biomed; 1997 Oct; 10(7):309-14. PubMed ID: 9471121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET of brain amyloid and tau in mild cognitive impairment.
    Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a spatial association between senile plaques and neurofibrillary tangles in Alzheimer's disease?
    Armstrong RA
    Folia Neuropathol; 2005; 43(3):133-8. PubMed ID: 16245206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senile dementia of the neurofibrillary tangle type: a comparison with Alzheimer's disease.
    Yamada M; Itoh Y; Sodeyama N; Suematsu N; Otomo E; Matsushita M; Mizusawa H
    Dement Geriatr Cogn Disord; 2001; 12(2):117-26. PubMed ID: 11173884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.